These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data. Dimov AV; Liu Z; Spincemaille P; Prince MR; Du J; Wang Y Magn Reson Med; 2018 Jan; 79(1):121-128. PubMed ID: 28261863 [TBL] [Abstract][Full Text] [Related]
3. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration. Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility underestimation in a high-susceptibility phantom: Dependence on imaging resolution, magnitude contrast, and other parameters. Zhou D; Cho J; Zhang J; Spincemaille P; Wang Y Magn Reson Med; 2017 Sep; 78(3):1080-1086. PubMed ID: 27699883 [TBL] [Abstract][Full Text] [Related]
5. Investigating the accuracy and precision of TE-dependent versus multi-echo QSM using Laplacian-based methods at 3 T. Biondetti E; Karsa A; Thomas DL; Shmueli K Magn Reson Med; 2020 Dec; 84(6):3040-3053. PubMed ID: 32491224 [TBL] [Abstract][Full Text] [Related]
6. Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping. Liu Z; Kee Y; Zhou D; Wang Y; Spincemaille P Magn Reson Med; 2017 Jul; 78(1):303-315. PubMed ID: 27464893 [TBL] [Abstract][Full Text] [Related]
7. On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping. Eskreis-Winkler S; Zhou D; Liu T; Gupta A; Gauthier SA; Wang Y; Spincemaille P Magn Reson Imaging; 2017 Jan; 35():154-159. PubMed ID: 27587225 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility weighted imaging and quantitative susceptibility mapping of the cerebral vasculature using ferumoxytol. Liu S; Brisset JC; Hu J; Haacke EM; Ge Y J Magn Reson Imaging; 2018 Mar; 47(3):621-633. PubMed ID: 28731570 [TBL] [Abstract][Full Text] [Related]
9. Cardiac quantitative susceptibility mapping (QSM) for heart chamber oxygenation. Wen Y; Nguyen TD; Liu Z; Spincemaille P; Zhou D; Dimov A; Kee Y; Deh K; Kim J; Weinsaft JW; Wang Y Magn Reson Med; 2018 Mar; 79(3):1545-1552. PubMed ID: 28653375 [TBL] [Abstract][Full Text] [Related]
10. Multicenter reproducibility of quantitative susceptibility mapping in a gadolinium phantom using MEDI+0 automatic zero referencing. Deh K; Kawaji K; Bulk M; Van Der Weerd L; Lind E; Spincemaille P; McCabe Gillen K; Van Auderkerke J; Wang Y; Nguyen TD Magn Reson Med; 2019 Feb; 81(2):1229-1236. PubMed ID: 30284727 [TBL] [Abstract][Full Text] [Related]
11. Background field removal using a region adaptive kernel for quantitative susceptibility mapping of human brain. Fang J; Bao L; Li X; van Zijl PCM; Chen Z J Magn Reson; 2017 Aug; 281():130-140. PubMed ID: 28595120 [TBL] [Abstract][Full Text] [Related]
12. Appropriate echo time selection for quantitative susceptibility mapping. Kanazawa Y; Matsumoto Y; Harada M; Hayashi H; Matsuda T; Otsuka H Radiol Phys Technol; 2019 Jun; 12(2):185-193. PubMed ID: 30980255 [TBL] [Abstract][Full Text] [Related]
13. Phase processing for quantitative susceptibility mapping of regions with large susceptibility and lack of signal. Fortier V; Levesque IR Magn Reson Med; 2018 Jun; 79(6):3103-3113. PubMed ID: 29130526 [TBL] [Abstract][Full Text] [Related]
14. Quantitative Susceptibility Mapping (QSM) Algorithms: Mathematical Rationale and Computational Implementations. Kee Y; Liu Z; Zhou L; Dimov A; Cho J; de Rochefort L; Seo JK; Wang Y IEEE Trans Biomed Eng; 2017 Nov; 64(11):2531-2545. PubMed ID: 28885147 [TBL] [Abstract][Full Text] [Related]
15. The effect of low resolution and coverage on the accuracy of susceptibility mapping. Karsa A; Punwani S; Shmueli K Magn Reson Med; 2019 Mar; 81(3):1833-1848. PubMed ID: 30338864 [TBL] [Abstract][Full Text] [Related]
16. Simulated and experimental phantom data for multi-center quality assurance of quantitative susceptibility maps at 3 T, 7 T and 9.4 T. Gustavo Cuña E; Schulz H; Tuzzi E; Biagi L; Bosco P; García-Fontes M; Mattos J; Tosetti M; Engelmann J; Scheffler K; Hagberg GE Phys Med; 2023 Jun; 110():102590. PubMed ID: 37116389 [TBL] [Abstract][Full Text] [Related]
17. Investigating hyperoxic effects in the rat brain using quantitative susceptibility mapping based on MRI phase. Hsieh MC; Kuo LW; Huang YA; Chen JH Magn Reson Med; 2017 Feb; 77(2):592-602. PubMed ID: 26834053 [TBL] [Abstract][Full Text] [Related]
18. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping. Chen Y; Liu S; Wang Y; Kang Y; Haacke EM Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394 [TBL] [Abstract][Full Text] [Related]
19. How to accurately quantify brain magnetic susceptibility in the context of Parkinson's disease: Validation on phantoms and healthy volunteers at 1.5 and 3 T. Hervouin A; Bézy-Wendling J; Noury F NMR Biomed; 2024 Nov; 37(11):e5182. PubMed ID: 38993048 [TBL] [Abstract][Full Text] [Related]
20. Background field removal technique based on non-regularized variable kernels sophisticated harmonic artifact reduction for phase data for quantitative susceptibility mapping. Kan H; Arai N; Takizawa M; Omori K; Kasai H; Kunitomo H; Hirose Y; Shibamoto Y Magn Reson Imaging; 2018 Oct; 52():94-101. PubMed ID: 29902566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]